United States Biotechnology & Medical Research

Satsuma Pharmaceuticals Inc (STSA)

Track

Ticker: STSA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Satsuma Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.4
TAKANASHI KEN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
323.18
Quantity 37,722 -9.7%
Value US$3,777,084
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.71
Quantity 150,000 +inf%
Value US$106,740
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.63
Quantity 300,694 +4.9%
Value US$188,956
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.63
Quantity 531,000 +9.5%
Value US$336,707
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.69
Quantity 5,608,306 +inf%
Value US$3,868,609
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Sale
Price
0.71
Quantity 3,250,000 -87.6%
Value US$2,294,500
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.42
Quantity 2,922 +0.1%
Value US$15,837
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.49
Quantity 9,979 +0.3%
Value US$54,785
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.44
Quantity 3,225 +0.1%
Value US$17,544
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
6.05
Quantity 7,941 +0.2%
Value US$48,043
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.85
Quantity 9,622 +0.3%
Value US$56,289
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.99
Quantity 560 +0.0%
Value US$3,354
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.95
Quantity 7,800 +0.2%
Value US$46,410
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.88
Quantity 1,400 +0.0%
Value US$8,232
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.64
Quantity 8,880 +0.2%
Value US$50,083
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.71
Quantity 44,651 +1.2%
Value US$254,957
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.55
Quantity 15,082 +0.4%
Value US$83,705
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.45
Quantity 39,581 +1.1%
Value US$215,716
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.51
Quantity 27,629 +0.8%
Value US$152,236
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.40
Quantity 32,816 +0.9%
Value US$177,206
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.44
Quantity 40,663 +1.2%
Value US$221,207
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
5.07
Quantity 87,580 +2.6%
Value US$444,031
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
4.87
Quantity 36,194 +1.1%
Value US$176,265
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
4.83
Quantity 126,000 +3.9%
Value US$608,580
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.68
Quantity 1,232,394 +31.4%
Value US$6,999,998
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.21
Quantity 1,000 -4.7%
Value US$22,210
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
22.19
Quantity 750 -100.0%
Value US$16,645
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 1,000 -100.0%
Value US$25,000
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
23.12
Quantity 200 -1.0%
Value US$4,624
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.85
Quantity 800 -3.8%
Value US$18,282
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.81
Quantity 100 -0.5%
Value US$2,781
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.99
Quantity 600 -2.9%
Value US$16,195
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.69
Quantity 300 -1.5%
Value US$7,707
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.59
Quantity 306 -100.0%
Value US$8,444
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
26.70
Quantity 394 -100.0%
Value US$10,520
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.63
Quantity 300 -100.0%
Value US$7,690
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.23
Quantity 2,115 -100.0%
Value US$74,512
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.26
Quantity 1,000 -4.7%
Value US$25,257
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.32
Quantity 1,000 -100.0%
Value US$25,324
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 2,000 -100.0%
Value US$50,000
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 1,000 -4.7%
Value US$20,000
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 800 -3.8%
Value US$16,000
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.25
Quantity 200 -1.0%
Value US$4,049
ALBRECHT DETLEF Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.42
Quantity 1,000 -4.7%
Value US$27,422
O'Neil Thomas P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.68
Quantity 1,000 -100.0%
Value US$27,678
1.4
TAKANASHI KEN
Transaction date
Purchase
Price
15.00
Quantity 233,333 +17.6%
Value US$3,499,995
1.4
Shah Rajeev M. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 192,387 +4.3%
Value US$2,885,805
1.4
Shah Rajeev M. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 1,140,946 +34.1%
Value US$17,114,190
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-08 2023-06-08 B Purchase
Shin Nippon Biomedical Laboratories, Ltd.
Large shareholder
23,104 +21.3%
112.02
US$2,459,559 		23,104 +21.3% 112.02 US$2,459,559
2023-06-08 2023-06-06 B Purchase
Shin Nippon Biomedical Laboratories, Ltd.
Large shareholder
47,633 -25.0%
396.63
US$1,131,790 		47,633 -25.0% 396.63 US$1,131,790
2023-06-08 2023-06-06 B Purchase
1.4
TAKANASHI KEN
Non-Executive Director Large shareholder
37,722 -9.7%
323.18
US$3,777,084 		37,722 -9.7% 323.18 US$3,777,084
2022-11-23 2022-11-21 B Purchase
2.9
Leonard Braden Michael
Large shareholder
150,000 +inf%
0.71
US$106,740 		150,000 +inf% 0.71 US$106,740
2022-11-16 2022-11-15 B Purchase
2.9
Leonard Braden Michael
Large shareholder
300,694 +4.9%
0.63
US$188,956 		300,694 +4.9% 0.63 US$188,956
2022-11-16 2022-11-15 B Purchase
2.9
Leonard Braden Michael
Large shareholder
531,000 +9.5%
0.63
US$336,707 		531,000 +9.5% 0.63 US$336,707
2022-11-16 2022-11-14 B Purchase
2.9
Leonard Braden Michael
Large shareholder
5,608,306 +inf%
0.69
US$3,868,609 		5,608,306 +inf% 0.69 US$3,868,609
2022-11-16 2022-11-14 S Sale
1.9
COMMODORE CAPITAL LP
Large shareholder
3,250,000 -87.6%
0.71
US$2,294,500 		3,250,000 -87.6% 0.71 US$2,294,500
2021-11-29 2021-11-24 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
2,922 +0.1%
5.42
US$15,837 		2,922 +0.1% 5.42 US$15,837
2021-11-23 2021-11-22 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
9,979 +0.3%
5.49
US$54,785 		9,979 +0.3% 5.49 US$54,785
2021-11-23 2021-11-19 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
3,225 +0.1%
5.44
US$17,544 		3,225 +0.1% 5.44 US$17,544
2021-11-12 2021-11-11 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
7,941 +0.2%
6.05
US$48,043 		7,941 +0.2% 6.05 US$48,043
2021-11-12 2021-11-10 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
9,622 +0.3%
5.85
US$56,289 		9,622 +0.3% 5.85 US$56,289
2021-11-10 2021-11-08 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
560 +0.0%
5.99
US$3,354 		560 +0.0% 5.99 US$3,354
2021-11-08 2021-11-05 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
7,800 +0.2%
5.95
US$46,410 		7,800 +0.2% 5.95 US$46,410
2021-11-08 2021-11-04 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
1,400 +0.0%
5.88
US$8,232 		1,400 +0.0% 5.88 US$8,232
2021-11-04 2021-11-02 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
8,880 +0.2%
5.64
US$50,083 		8,880 +0.2% 5.64 US$50,083
2021-11-02 2021-10-29 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
44,651 +1.2%
5.71
US$254,957 		44,651 +1.2% 5.71 US$254,957
2021-10-29 2021-10-28 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
15,082 +0.4%
5.55
US$83,705 		15,082 +0.4% 5.55 US$83,705
2021-10-29 2021-10-27 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
39,581 +1.1%
5.45
US$215,716 		39,581 +1.1% 5.45 US$215,716
2021-10-25 2021-10-22 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
27,629 +0.8%
5.51
US$152,236 		27,629 +0.8% 5.51 US$152,236
2021-10-25 2021-10-21 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
32,816 +0.9%
5.40
US$177,206 		32,816 +0.9% 5.40 US$177,206
2021-10-21 2021-10-20 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
40,663 +1.2%
5.44
US$221,207 		40,663 +1.2% 5.44 US$221,207
2021-10-21 2021-10-19 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
87,580 +2.6%
5.07
US$444,031 		87,580 +2.6% 5.07 US$444,031
2021-10-19 2021-10-18 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
36,194 +1.1%
4.87
US$176,265 		36,194 +1.1% 4.87 US$176,265
2021-10-19 2021-10-15 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
126,000 +3.9%
4.83
US$608,580 		126,000 +3.9% 4.83 US$608,580
2021-03-02 2021-02-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,232,394 +31.4%
5.68
US$6,999,998 		1,232,394 +31.4% 5.68 US$6,999,998
2020-09-03 2020-09-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
22.21
US$22,210 		1,000 -4.7% 22.21 US$22,210
2020-09-03 2020-09-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
750 -100.0%
22.19
US$16,645 		750 -100.0% 22.19 US$16,645
2020-08-07 2020-08-05 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
1,000 -100.0%
25.00
US$25,000 		1,000 -100.0% 25.00 US$25,000
2020-08-05 2020-08-03 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
200 -1.0%
23.12
US$4,624 		200 -1.0% 23.12 US$4,624
2020-08-05 2020-08-03 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
800 -3.8%
22.85
US$18,282 		800 -3.8% 22.85 US$18,282
2020-07-02 2020-07-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
100 -0.5%
27.81
US$2,781 		100 -0.5% 27.81 US$2,781
2020-07-02 2020-07-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
600 -2.9%
26.99
US$16,195 		600 -2.9% 26.99 US$16,195
2020-07-02 2020-07-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
300 -1.5%
25.69
US$7,707 		300 -1.5% 25.69 US$7,707
2020-07-02 2020-07-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
306 -100.0%
27.59
US$8,444 		306 -100.0% 27.59 US$8,444
2020-07-02 2020-07-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
394 -100.0%
26.70
US$10,520 		394 -100.0% 26.70 US$10,520
2020-07-02 2020-07-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
300 -100.0%
25.63
US$7,690 		300 -100.0% 25.63 US$7,690
2020-06-24 2020-06-23 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
2,115 -100.0%
35.23
US$74,512 		2,115 -100.0% 35.23 US$74,512
2020-06-02 2020-06-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
25.26
US$25,257 		1,000 -4.7% 25.26 US$25,257
2020-06-02 2020-06-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
1,000 -100.0%
25.32
US$25,324 		1,000 -100.0% 25.32 US$25,324
2020-05-21 2020-05-20 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
2,000 -100.0%
25.00
US$50,000 		2,000 -100.0% 25.00 US$50,000
2020-05-06 2020-05-05 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
20.00
US$20,000 		1,000 -4.7% 20.00 US$20,000
2020-04-16 2020-04-14 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
800 -3.8%
20.00
US$16,000 		800 -3.8% 20.00 US$16,000
2020-04-03 2020-04-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
200 -1.0%
20.25
US$4,049 		200 -1.0% 20.25 US$4,049
2020-03-12 2020-03-11 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
27.42
US$27,422 		1,000 -4.7% 27.42 US$27,422
2020-03-12 2020-03-11 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
1,000 -100.0%
27.68
US$27,678 		1,000 -100.0% 27.68 US$27,678
2019-09-18 2019-09-17 B Purchase
3.7
TPG Group Holdings (SBS) Advisors, Inc.
Large shareholder
100,000 +5.6%
15.00
US$1,500,000 		100,000 +5.6% 15.00 US$1,500,000
2019-09-17 2019-09-17 B Purchase
1.4
TAKANASHI KEN
233,333 +17.6%
15.00
US$3,499,995 		233,333 +17.6% 15.00 US$3,499,995
2019-09-17 2019-09-17 B Purchase
1.4
Shah Rajeev M.
Large shareholder
192,387 +4.3%
15.00
US$2,885,805 		192,387 +4.3% 15.00 US$2,885,805
2019-09-17 2019-09-17 B Purchase
1.4
Shah Rajeev M.
Large shareholder
1,140,946 +34.1%
15.00
US$17,114,190 		1,140,946 +34.1% 15.00 US$17,114,190
2019-09-17 2019-09-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, LLC
Large shareholder
1,333,333 +39.8%
15.00
US$19,999,995 		1,333,333 +39.8% 15.00 US$19,999,995
Explore more

More insider trading research around Satsuma Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America